Sex-based analysis of first-line immune-based combinations in intermediate/poor-risk papillary, chromophobe, and unclassified renal cell carcinoma: an ARON-1 subanalysis

Frontiers in Oncology

The paper

Paola I. Valdez-Sandoval, Evelyn Lilian Beas-Lozano, Zin W. Myint,

Jakub Kucharz, Veronica Mollica, Alessandro Rizzo, Tarek Taha, Johannes Landmesser, Esther Pérez Calabuig, Jawaher Ansari, Cinzia Ortega, Ravindran Kanesvaran, Dipen Bhuva, Anca Florina Zgura, Ondřej Fiala, Javier Molina‐Cerrillo, Sebastiano Buti, Francesco Massari, María Fernanda Esparza-Orozco, Matteo Santoni,

Maria Teresa Bourlon

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Frontiers in Oncology · 26 Aug 2026

doi.org/10.3389/fonc.2026.1911444 PubMed 42718726

Sex-based analysis of first-line immune-based combinations in intermediate/poor-risk papillary, chromophobe, and unclassified renal cell carcinoma: an ARON-1 subanalysis

The paper

Drug class linked to fewer deaths or complications in kidney disease

Diabetes drug class linked to slightly less frailty progression

Ketogenic diet improved heart function in aged mice

Scaffold and metformin sped new bone formation in aged mice

Sex-based analysis of first-line immune-based combinations in intermediate/poor-risk papillary, chromophobe, and unclassified renal cell carcinoma: an ARON-1 subanalysis

The paper

More in Interventions